Education
About Us
Working with TipRanks
Follow Us
Spencer Pharmaceutical Inc. (SPPH)
:SPPH
SPPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.14 - $0.14
Previous CloseN/A
Volume1.00K
Average Volume (3M)N/A
Market Cap
$294.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding294,363,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
SPPH FAQ
What was Spencer Pharmaceutical Inc.’s price range in the past 12 months?
Spencer Pharmaceutical Inc. lowest stock price was $0.14 and its highest was $0.14 in the past 12 months.
What is Spencer Pharmaceutical Inc.’s market cap?
Spencer Pharmaceutical Inc.’s market cap is $294.00.
When is Spencer Pharmaceutical Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Spencer Pharmaceutical Inc.’s earnings last quarter?
Currently, no data Available
Is Spencer Pharmaceutical Inc. overvalued?
According to Wall Street analysts Spencer Pharmaceutical Inc.’s price is currently Overvalued.
Does Spencer Pharmaceutical Inc. pay dividends?
Spencer Pharmaceutical Inc. does not currently pay dividends.
What is Spencer Pharmaceutical Inc.’s EPS estimate?
Spencer Pharmaceutical Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spencer Pharmaceutical Inc. have?
Spencer Pharmaceutical Inc. has 294,363,000 shares outstanding.
What happened to Spencer Pharmaceutical Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Spencer Pharmaceutical Inc.?
Currently, no hedge funds are holding shares in SPPH
Company Description
Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Hepion Pharmaceuticals
―
Revelation Biosciences
―
Virpax Pharmaceuticals
―